U.S. Office-based Labs Market Size to Hit Around USD 23.87 Bn by 2034
The U.S. office-based labs market size was exhibited at USD 11.55 billion in 2024 and is projected to hit around USD 23.87 billion by 2034, growing at a CAGR of 7.53% during the forecast period 2025 to 2034.
?????????????? ?????? ???????? ???????????? ????????????: https://www.novaoneadvisor.com/report/sample/8239
Key Insights on the U.S. Office-Based Labs Market:
The rising trend of performing surgical procedures in outpatient settings, coupled with the increasing prevalence of vascular diseases, is driving the demand for office-based labs (OBLs) in the U.S. High patient satisfaction, attributed to dedicated and specialized medical teams, is further fueling market growth.
The incidence of vascular diseases has surged over the past decade and is expected to continue rising exponentially. For instance, the U.S. saw a 13% increase in Peripheral Artery Disease (PAD) cases over the last ten years. PAD elevates the risk of stroke, heart attack, and ischemic amputations, thereby boosting the demand for vascular surgeries. Leading service providers like National Cardiovascular Partners, Envision Healthcare, and Surgery Partners are offering cost-effective office-based surgical solutions to meet this demand.
Major manufacturers, including Philips Healthcare and Siemens Healthineers, are collaborating with physicians to establish OBLs, equipping them with necessary devices and providing end-to-end solutions. These partnerships are expected to accelerate market growth. Additionally, evolving reimbursement policies for surgical procedures are expanding the scope of outpatient surgeries. In 2021, the Centers for Medicare and Medicaid Services introduced new standards for reimbursed procedures in Ambulatory Surgery Centers (ASCs) and expanded the list of surgeries covered in outpatient settings.
This policy shift has positively impacted peripheral vascular interventions, which are now classified under outpatient settings, making them more cost-effective than inpatient procedures. OBLs offer better reimbursement benefits for physicians compared to Hospital Outpatient (HO) settings. While ambulatory centers have higher operating costs due to stringent safety standards and regulatory requirements, OBLs present a more viable option. In some U.S. states, converting an ambulatory center requires a time-consuming certificate of need, creating opportunities for physicians to transition to OBLs.
U.S. Office-Based Labs Market by Modality
The market is segmented into single-specialty, multi-specialty, and hybrid labs. In 2024, the single-specialty segment dominated, driven by its cost-efficiency and focus on specific specialties like ophthalmology, urology, plastics, and gastroenterology. Single-specialty clinics require fewer resources compared to multi-specialty hospitals, reducing operational costs.
The hybrid labs segment is expected to grow at the fastest CAGR due to technological advancements, higher reimbursement rates, and the increasing popularity of minimally invasive procedures. Hybrid labs operate as OBLs on certain days and as ASCs on others, enhancing procedure volume, reimbursement efficiency, and resource utilization.
U.S. Office-Based Labs Market by Service
The market is categorized into peripheral vascular intervention, endovascular intervention, cardiac, interventional radiology, venous, and others. The peripheral vascular intervention segment led in 2024, driven by the rising prevalence of PAD, favorable reimbursement policies, and advancements in minimally invasive techniques.
Industry players are expanding their peripheral intervention offerings to capitalize on OBL opportunities. For example, in March 2021, Cardiovascular Systems, Inc. acquired WavePoint Medical’s peripheral support catheters to strengthen its product portfolio.
The interventional radiology segment is expected to grow at the fastest CAGR. Interventional radiology is gaining traction in value-based healthcare models due to its minimally invasive, cost-effective, and less painful procedures. It uses image-guided techniques like MRI, CT, and ultrasound to diagnose and treat diseases across organ systems. According to the Cardiovascular Disease Management Annual Symposium, approximately 12% of interventional radiologists in the U.S. perform office-based interventions.
U.S. Office-Based Labs Market by Specialist
The market is segmented into vascular surgeons, interventional cardiologists, interventional radiologists, and others. Vascular surgeons dominated in 2024, supported by advancements in medical technology, increased demand for specialists, and a shift toward OBLs for efficient care.
The interventional radiologist segment is projected to grow at the fastest rate, driven by the adoption of minimally invasive image-guided techniques. Factors such as technological advancements, patient demographics, and the preference for efficient care are boosting demand for vascular specialists.
Currently, there is a shortage of vascular surgeons in the U.S., with 100 million people at risk of vascular diseases, as reported by the Society for Vascular Surgery. OBLs are preferred by vascular surgeons due to their financial benefits, as surgeons retain the margins from procedures. Additionally, interventional radiology reduces costs, recovery time, pain, and risks for patients.
Key Players in the U.S. Office-Based Labs Market
Manufacturers:
Service Providers
Recent Developments in the U.S. Office-Based Labs Market
Market Segmentation
This report provides revenue growth forecasts and analyzes industry trends across sub-segments from 2021 to 2034. The U.S. office-based labs market is segmented as follows:
By Modality:
By Service:
By Specialist
Immediate Delivery Available | Buy This Premium Research https://www.novaoneadvisor.com/report/checkout/8239
Access our Premium Real Time Data Intelligence Tool, Visit: https://www.statifacts.com/
You can place an order or ask any questions, please feel free to [email protected]| +1 9197 992 333
About US
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
Connect with Us
Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
IND Address: 707, Nandan Probiz, Baner,?Pune (MH) – 411045, India
USA:?+1 804 441 9344
APAC:?+61 485 981 310 or +91 87933 22019
Europe:?+44 7383 092 044
Email: [email protected]
You can place an order or ask any questions, please feel free to contact at?[email protected] ?| +1 804 441 9344
Nova One Advisor Group Offer Other Reports:
U.S. Telemedicine Market- https://www.biospace.com/press-releases/u-s-telemedicine-market-size-to-hit-usd-160-45-billion-by-2034
Pyrogen Testing Market- https://www.biospace.com/press-releases/pyrogen-testing-market-size-to-hit-usd-3-52-billion-by-2034
DNA Sequencing Market- https://www.biospace.com/press-releases/dna-sequencing-market-size-to-hit-usd-106-20-billion-by-2034
Infection Control Market- https://www.biospace.com/press-releases/infection-control-market-size-to-hit-usd-438-67-billion-by-2034
Cell Analysis Market - https://www.biospace.com/press-releases/cell-analysis-market-size-to-hit-usd-80-14-billion-by-2034
Cell-based Assays Market - https://www.biospace.com/press-releases/cell-based-assays-market-size-to-surpass-usd-41-1-billion-by-2034
Compression Therapy Market - https://www.biospace.com/press-releases/compression-therapy-market-size-to-hit-usd-9-28-billion-by-2034
Proteomics Market- https://www.biospace.com/press-releases/proteomics-market-to-reach-usd-95-81-billion-to-2034-exclusive-report-by-nova-one-advisor